GO:0006654 phosphatidic acid biosynthetic process: Lipid Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006654 phosphatidic acid biosynthetic process describes the enzymatic reactions that generate phosphatidic acid (PA), a glycerol phosphate with both remaining hydroxyls esterified to fatty acids.
• PA is a central lipid intermediate and a potent signaling molecule that regulates membrane trafficking, cell growth, and stress responses.
• Key enzymes include glycerol-3-phosphate acyltransferases (GPATs), lysophosphatidic acid acyltransferases (LPAATs), diacylglycerol kinases (DGKs), and phospholipase D (PLD).
• Dysregulation of PA biosynthesis is linked to cancer, neurodegeneration, and immune disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of PA biosynthetic enzymes in disease and development.
• Studying this process requires lipidomics, live-cell imaging, and genetic screens to map PA dynamics and downstream effectors.
Description
Phosphatidic acid (PA) is the simplest glycerophospholipid and a key intermediate in lipid biosynthesis, but it is also a potent second messenger that regulates diverse cellular processes. The Gene Ontology term GO:0006654, phosphatidic acid biosynthetic process, encompasses the chemical reactions and pathways that produce PA, defined as any derivative of glycerol phosphate in which both remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids. This process is essential for membrane biogenesis, energy storage, and signal transduction, and its dysregulation contributes to cancer, neurodegeneration, and immune dysfunction. Researchers study PA biosynthesis to understand how cells coordinate lipid metabolism with growth, stress responses, and disease progression. The pathway involves multiple enzymatic routes, including acylation of glycerol-3-phosphate, phosphorylation of diacylglycerol, and hydrolysis of phospholipids, each generating PA with distinct acyl chain compositions and signaling properties.
phosphatidic acid biosynthetic process At A Glance
| GO ID | GO:0006654 |
|---|---|
| GO term | phosphatidic acid biosynthetic process |
| Ontology | biological_process |
| Synonym | phosphatidate biosynthesis; phosphatidic acid anabolism; phosphatidic acid biosynthesis; phosphatidic acid formation; phosphatidic acid synthesis |
| Major function | Synthesis of phosphatidic acid, a key intermediate in glycerolipid metabolism and a signaling lipid |
| Key enzymes | GPAT, LPAAT, DGK, PLD, and related acyltransferases |
| Subcellular locations | Endoplasmic reticulum, mitochondria, inner nuclear membrane, plasma membrane |
| Related pathways | Glycerophospholipid metabolism, triacylglycerol synthesis, phospholipase D signaling |
What Is GO:0006654?
GO:0006654 phosphatidic acid biosynthetic process is defined as the chemical reactions and pathways resulting in the formation of phosphatidic acid, any derivative of glycerol phosphate in which both remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids. In simpler terms, it is the set of enzymatic steps that build PA, a lipid that serves both as a membrane building block and as a signaling molecule.
Why Is phosphatidic acid biosynthetic process Important in Cell Biology?
Phosphatidic acid biosynthetic process is fundamental to cell biology because PA sits at the crossroads of lipid metabolism and signal transduction. It is required for membrane synthesis and remodeling, and it acts as a lipid second messenger that recruits effector proteins to membranes, modulates enzyme activity, and influences vesicle trafficking. Dysregulated PA production is implicated in cancer cell proliferation, neurodegeneration, and immune responses, making this pathway a target for therapeutic intervention and a focus for understanding cellular stress and metabolic reprogramming.
• PA is a precursor for the synthesis of diacylglycerol, phosphatidylinositol, and cardiolipin, linking it to diverse lipid-dependent processes.
• PA regulates membrane curvature and fission/fusion events, impacting organelle dynamics and vesicle transport.
• PA-mediated signaling influences cell proliferation, survival, and migration, with implications for cancer.
• DGK-mediated PA bursts are critical for plant immunity and likely similar stress responses in other systems.
• PA modulates neurotransmission and synaptic function, connecting it to neurological disorders.
• Seipin governs PA homeostasis at the inner nuclear membrane, affecting nuclear envelope integrity.
• Mitochondrial PA signaling affects bioenergetics and apoptosis.
• Cyclic PA inhibits growth in colon cancer cells, highlighting therapeutic potential.
• PA is involved in inflammatory signaling and immune cell activation.
• Understanding PA biosynthesis aids in developing drugs targeting lipid signaling in disease.
What Happens During phosphatidic acid biosynthetic process?
De Novo Synthesis via Glycerol-3-Phosphate Acylation
In simple terms: The cell builds PA from scratch by attaching fatty acids to a glycerol backbone.
The de novo pathway begins with glycerol-3-phosphate (G3P), which is acylated by glycerol-3-phosphate acyltransferases (GPATs) to form lysophosphatidic acid (LPA). LPA is then further acylated by lysophosphatidic acid acyltransferases (LPAATs) to yield PA. This route is a major source of PA for membrane biogenesis and storage lipid synthesis, and it is regulated by enzymes such as GPAT and LPAAT in response to metabolic demands.
Phosphorylation of Diacylglycerol by DGK
In simple terms: Another way to make PA is by adding a phosphate group to diacylglycerol.
Diacylglycerol kinases (DGKs) phosphorylate diacylglycerol (DAG) to produce PA, a reaction that also consumes ATP. DGK isoforms are subject to complex regulation, including phosphorylation and membrane recruitment, and they generate PA bursts that act as signals in processes such as neurotransmission and immune responses. For example, dual phosphorylation of DGK5 mediates PA burst in plant immunity.
Phospholipase D-Mediated PA Formation
In simple terms: PA can also be made by cutting a lipid called phosphatidylcholine.
Phospholipase D (PLD) hydrolyzes phospholipids such as phosphatidylcholine to generate PA and a soluble alcohol. This route is particularly important for rapid PA production during signaling events, including vesicle trafficking and stress responses. PLD-derived PA often has distinct acyl chain composition and can be further converted to other lipids, contributing to signal diversity.
Acylation and Remodeling of PA
In simple terms: PA molecules can be modified by swapping fatty acids to change their properties.
PA can undergo acyl chain remodeling through the action of acyltransferases and phospholipases, generating molecular species with different saturation and length. This remodeling affects PA's biophysical properties and its interaction with effector proteins, influencing signaling specificity. Enzymes such as LPAAT and phospholipase A are involved in these remodeling steps.
Subcellular Compartmentalization of PA Synthesis
In simple terms: PA is made in different parts of the cell, and where it is made matters for its function.
PA biosynthesis occurs at multiple subcellular sites, including the endoplasmic reticulum, mitochondria, and inner nuclear membrane. Seipin, a protein at the inner nuclear membrane, governs PA homeostasis and affects nuclear envelope structure. Mitochondrial PA signaling is linked to bioenergetics and apoptosis. This compartmentalization allows distinct pools of PA to carry out specific functions, from membrane expansion to organelle communication.
Key Genes Involved in GO:0006654 phosphatidic acid biosynthetic process
The following genes and proteins are central to phosphatidic acid biosynthetic process, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPAT1 | Glycerol-3-phosphate acyltransferase, catalyzes first step of de novo PA synthesis | Metabolic disorders, hepatic steatosis |
| GPAT2 | Glycerol-3-phosphate acyltransferase, contributes to PA synthesis | Cancer metabolism, testis-specific functions |
| AGPAT1 | Lysophosphatidic acid acyltransferase, converts LPA to PA | Lipid biosynthesis, membrane biogenesis |
| AGPAT2 | Lysophosphatidic acid acyltransferase, converts LPA to PA | Congenital generalized lipodystrophy |
| DGKα | Diacylglycerol kinase, phosphorylates DAG to PA | T-cell signaling, cancer immunotherapy |
| DGKθ | Diacylglycerol kinase, regulated by phosphorylation | Neuronal signaling, synaptic plasticity |
| DGK5 | Plant diacylglycerol kinase, mediates PA burst in immunity | Plant immunity, ROS signaling |
| PLD1 | Phospholipase D, hydrolyzes phospholipids to PA | Vesicle trafficking, cancer metastasis |
| PLD2 | Phospholipase D, generates PA for signaling | Cell migration, inflammation |
| Seipin | Governs PA homeostasis at inner nuclear membrane | Nuclear envelope organization, lipodystrophy |
| CDS1 | CDP-diacylglycerol synthase, uses PA for PI synthesis | Phosphoinositide signaling |
| CDS2 | CDP-diacylglycerol synthase, uses PA for PI synthesis | Phosphoinositide signaling |
| PAP | Phosphatidic acid phosphatase, converts PA to DAG | Lipid storage, signaling termination |
| LPP3 | Lipid phosphate phosphatase, dephosphorylates PA | Vascular development, cancer |
| mTOR | Kinase that senses PA and regulates growth | Cell growth, metabolism |
| Raf-1 | Kinase recruited by PA to membranes | MAPK signaling, cancer |
| PIP5K | Phosphatidylinositol-4-phosphate 5-kinase, activated by PA | Actin dynamics, endocytosis |
| SphK1 | Sphingosine kinase 1, regulated by PA | Sphingolipid signaling, cancer |
How Is phosphatidic acid biosynthetic process Regulated?
Phosphatidic acid biosynthesis is regulated at multiple levels. Enzymes such as DGK and PLD are controlled by phosphorylation, calcium, and lipid interactions. For instance, DGKθ is regulated by phosphorylation, and DGK5 in plants is activated by dual phosphorylation during immune responses. PA levels are also influenced by lipid phosphate phosphatases and PA phosphatases that degrade PA. Additionally, PA can feedback to regulate its own synthesis by modulating enzyme activity or localization. Growth factor signaling via mTOR and Raf-1 can impact PA production and downstream effects.
phosphatidic acid biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AGPAT2 | Congenital generalized lipodystrophy | Knockout adipocytes, patient iPSCs |
| DGKα | T-cell signaling, cancer immunotherapy | Knockout T cells, xenograft models |
| PLD1 | Cancer metastasis, vesicle trafficking | Overexpression in cancer cell lines |
| Seipin | Lipodystrophy, nuclear envelope defects | Knock-in mutations in HeLa or fibroblasts |
| DGK5 | Plant immunity, ROS signaling | Arabidopsis knockout and point mutants |
Cancer
Phosphatidic acid promotes cell proliferation and survival through activation of mTOR, Raf-1, and other effectors. Elevated PA levels and altered expression of PA biosynthetic enzymes, such as DGK and PLD, are observed in various cancers. Cyclic PA, a derivative, inhibits growth in human colon cancer cells, suggesting that modulating PA signaling could be therapeutic.
Neurodegeneration and Neurotransmission
PA is involved in neurotransmission and synaptic function, and its dysregulation may contribute to neurological disorders. DGKθ, a PA-producing enzyme, is important in neuronal signaling. PA also affects mitochondrial function, which is critical in neurodegenerative diseases.
Immune and Inflammatory Disorders
PA bursts mediated by DGK5 are essential for plant immunity, and similar mechanisms may operate in mammalian immune cells. PA regulates inflammatory signaling and immune cell activation, linking it to autoimmune and inflammatory conditions.
Metabolic and Lipodystrophy Disorders
Mutations in AGPAT2 cause congenital generalized lipodystrophy, highlighting the importance of PA biosynthesis in adipose tissue development. Seipin, which governs PA homeostasis at the inner nuclear membrane, is linked to lipodystrophy and nuclear envelope defects.
From phosphatidic acid biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GPAT1 reduce PA levels and affect lipid storage? | GPAT1 knockout cell line (e.g., HepG2) |
| How does a specific DGK phosphorylation site regulate PA burst? | Point mutation knock-in of DGK in HEK293 cells |
| Can PA biosynthetic enzyme be tagged for live imaging? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of PLD1 increase PA and promote migration? | PLD1 overexpression in cancer cell lines |
| What is the role of Seipin in nuclear envelope PA homeostasis? | Seipin knockout and rescue with mutants |
| Can CRISPR library screening identify synthetic lethal partners with PA pathway? | Genome-wide CRISPR knockout screen in PA-enzyme mutant background |
How to Study the phosphatidic acid biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS/MS) | PA species and other lipids | Quantify PA changes in knockout cells |
| PA biosensor imaging | Real-time PA dynamics | Visualize PA at membranes |
| CRISPR knockout screen | Genes affecting PA levels or synthetic lethality | Identify novel regulators |
| DGK activity assay | Conversion of DAG to PA | Measure enzyme kinetics |
| PLD activity assay | Hydrolysis of phospholipids to PA | Test inhibitors |
| Phosphorylation analysis | Post-translational modifications of enzymes | Study regulation of DGK |
| Subcellular fractionation | PA distribution across organelles | Map compartmentalized synthesis |
| Co-immunoprecipitation | Protein-protein interactions with PA enzymes | Identify signaling complexes |
Lipidomics and Mass Spectrometry
Mass spectrometry-based lipidomics allows quantification of PA species and other lipids, providing direct readout of PA biosynthetic activity. This method can distinguish acyl chain compositions and track changes in response to genetic or pharmacological perturbations.
Live-Cell Imaging with PA Biosensors
Genetically encoded PA biosensors, such as those based on PA-binding domains, enable real-time visualization of PA dynamics at subcellular locations. These tools help map where and when PA is produced during signaling events.
Genetic Screens and CRISPR Libraries
CRISPR knockout libraries can be used to identify genes that modulate PA levels or that are synthetic lethal with PA pathway mutations. Such screens can uncover novel regulators and therapeutic targets.
Biochemical Enzyme Assays
In vitro assays measuring GPAT, LPAAT, DGK, or PLD activity using radiolabeled substrates or fluorescent analogs provide direct enzymatic readouts. These assays are useful for validating inhibitors and studying kinetics.
How CRISPR Can Be Used to Study GO:0006654 phosphatidic acid biosynthetic process
Knockout
CRISPR knockout of PA biosynthetic genes (e.g., GPAT1, DGKα, PLD1) enables loss-of-function studies to determine their role in PA production and downstream phenotypes. Knockout cell lines can be used for lipidomics, signaling assays, and disease models.
Point Mutation
Point mutations can be introduced to study specific phosphorylation sites or catalytic residues, such as in DGK5, to dissect regulatory mechanisms without completely abolishing protein function. This approach is valuable for understanding how post-translational modifications control PA bursts.
Knock-in
Knock-in of tags (e.g., GFP, HA) at endogenous loci allows visualization and purification of PA enzymes under native regulation. Knock-in of disease-associated mutations (e.g., in AGPAT2 or Seipin) can model human disorders.
Overexpression
Overexpression of PA biosynthetic enzymes (e.g., PLD1, DGKθ) can elevate PA levels and reveal gain-of-function phenotypes, such as increased proliferation or migration. This is useful for studying oncogenic roles of PA signaling.
How EDITGENE Supports phosphatidic acid biosynthetic process Research
Researchers studying phosphatidic acid biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in PA production, signaling, or disease. EDITGENE provides comprehensive CRISPR services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for phosphatidic acid biosynthetic process research.
Frequently Asked Questions About phosphatidic acid biosynthetic process
What is phosphatidic acid biosynthetic process?
It is the set of enzymatic reactions that produce phosphatidic acid, a key lipid intermediate and signaling molecule, as defined by GO:0006654.
What genes are involved in phosphatidic acid biosynthetic process?
Key genes include GPAT1, AGPAT1/2, DGK isoforms, PLD1/2, and Seipin, among others.
How is phosphatidic acid made in cells?
PA is made via acylation of glycerol-3-phosphate, phosphorylation of diacylglycerol by DGK, or hydrolysis of phospholipids by PLD.
Why is phosphatidic acid important for cell signaling?
PA recruits and activates proteins like mTOR and Raf-1, and regulates membrane trafficking and immune responses.
What diseases are linked to phosphatidic acid biosynthesis?
Cancer, neurodegeneration, immune disorders, and lipodystrophies have been associated with PA pathway dysregulation.
How can I study phosphatidic acid biosynthesis using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of PA enzymes for functional studies.
What methods measure phosphatidic acid levels?
Lipidomics by mass spectrometry, PA biosensors, and enzyme activity assays are commonly used.
What is the role of DGK in PA biosynthesis?
DGK phosphorylates diacylglycerol to produce PA, and its activity is regulated by phosphorylation and other signals.
How does Seipin affect phosphatidic acid?
Seipin governs PA homeostasis at the inner nuclear membrane, influencing nuclear envelope structure.
Can phosphatidic acid biosynthesis be targeted for cancer therapy?
Yes, inhibitors of PA-producing enzymes like PLD and DGK are being explored, and cyclic PA shows growth inhibition in colon cancer cells.
Conclusion
Phosphatidic acid biosynthetic process (GO:0006654) is a fundamental metabolic pathway that produces a lipid with dual roles in membrane biogenesis and signal transduction. Its dysregulation is implicated in cancer, neurodegeneration, immune disorders, and metabolic diseases, making it a rich area for research. Advances in CRISPR genome editing and lipidomics now enable precise dissection of this pathway, offering opportunities for therapeutic targeting and deeper understanding of cellular regulation.
References
- 1. Romanauska A et al.. 2024. Seipin governs phosphatidic acid homeostasis at the inner nuclear membrane.. Nat Commun 15(1):10486 PMID: 39622802
- 2. Liu Y et al.. 2013. Phosphatidic acid-mediated signaling.. Adv Exp Med Biol 991:159-76 PMID: 23775695
- 3. Kong L et al.. 2024. Dual phosphorylation of DGK5-mediated PA burst regulates ROS in plant immunity.. Cell 187(3):609-623.e21 PMID: 38244548
- 4. Raben DM et al.. 2017. Phosphatidic acid and neurotransmission.. Adv Biol Regul 63:15-21 PMID: 27671966
- 5. Tsukahara T et al.. 2013. Cyclic phosphatidic acid stimulates cAMP production and inhibits growth in human colon cancer cells.. PLoS One 8(11):e81139 PMID: 24282571
- 6. Yang CY et al.. 2012. Mitochondria: signaling with phosphatidic acid.. Int J Biochem Cell Biol 44(8):1346-50 PMID: 22609101
- 7. Tu-Sekine B et al.. 2009. Regulation of DGK-theta.. J Cell Physiol 220(3):548-52 PMID: 19472209
- 8. Wang X et al.. 2006. Signaling functions of phosphatidic acid.. Prog Lipid Res 45(3):250-78 PMID: 16574237
